Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Of Intravenous T900607-Sodium In Subjects With Chemotherapy-Naive Unresectable Hepatocellular Carcinoma

NCT00054262 is registered in ClinicalTrials.gov with University Hospitals Seidman Cancer Center as lead sponsor.

NCT NCT00054262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00054262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Of Intravenous T900607-Sodium In Subjects With Chemotherapy-Naive Unresectable Hepatocellular Carcinoma
Lead sponsor
University Hospitals Seidman Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
September 30, 2010
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer